PCN176 - A COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB VERSUS DOCETAXEL FOR PREVIOUSLY TREATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN BELGIUM

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.259
https://www.valueinhealthjournal.com/article/S1098-3015(18)33559-9/fulltext
Section Title :
Section Order : 1951
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33559-9&doi=10.1016/j.jval.2018.09.259
HEOR Topics :
Tags :
Regions :